Jilin Province Huinan Changlong Bio-pharmacy Company Limited (HKG:8049)
2.020
-0.040 (-1.94%)
At close: Feb 13, 2026
HKG:8049 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 485.12 | 235.85 | 352.14 | 113.6 | 55.29 | 26.02 |
Short-Term Investments | 209.92 | 254.48 | 215.32 | 673.13 | 68.43 | 197.12 |
Trading Asset Securities | 53.27 | 93.27 | 90.61 | 263.07 | 176.53 | 60.42 |
Cash & Short-Term Investments | 748.3 | 583.59 | 658.06 | 1,050 | 300.26 | 283.55 |
Cash Growth | 15.89% | -11.32% | -37.32% | 249.63% | 5.89% | -67.18% |
Accounts Receivable | 276.05 | 412.91 | 395.36 | 451.02 | 399.61 | 414.61 |
Other Receivables | 216.79 | 5.33 | 8.71 | 116.52 | 96.67 | 46.15 |
Receivables | 492.84 | 418.23 | 404.06 | 567.54 | 496.28 | 460.76 |
Inventory | 87.18 | 59.97 | 102.97 | 132.99 | 86.31 | 55 |
Other Current Assets | - | 37.25 | 36.05 | 17.15 | 7.02 | 8.58 |
Total Current Assets | 1,328 | 1,099 | 1,201 | 1,767 | 889.87 | 807.89 |
Property, Plant & Equipment | 300.61 | 313.07 | 329.55 | 360.28 | 398.15 | 346.59 |
Long-Term Investments | 949.04 | 1,049 | 724.16 | 211.41 | 776.49 | 648.52 |
Goodwill | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 | - |
Other Intangible Assets | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 | - |
Long-Term Deferred Tax Assets | 35.35 | 34.32 | 28.51 | 27.4 | 1.51 | 1.51 |
Other Long-Term Assets | 28.77 | 29.66 | 29.2 | - | - | - |
Total Assets | 2,648 | 2,531 | 2,319 | 2,373 | 2,072 | 1,805 |
Accounts Payable | 66.06 | 63.54 | 70.58 | 65.69 | 51.34 | 42.63 |
Accrued Expenses | 24.16 | 366.62 | 299.85 | 295.28 | 33.78 | 193.37 |
Current Portion of Long-Term Debt | 72.4 | 72.4 | 8.4 | 0.4 | 0.4 | 0.4 |
Current Income Taxes Payable | 3.66 | 3.61 | 16.68 | 25.66 | 32.45 | 26.64 |
Current Unearned Revenue | 22.63 | 22.63 | 16.32 | 24.94 | 16.81 | 8.55 |
Other Current Liabilities | 686.38 | 331.87 | 313.45 | 302.63 | 437.03 | 143.84 |
Total Current Liabilities | 875.29 | 860.67 | 725.29 | 714.59 | 571.79 | 415.44 |
Long-Term Debt | 3.93 | - | 72 | - | - | - |
Long-Term Unearned Revenue | 34.95 | 34.95 | 35.54 | 40.97 | 41.95 | 43.19 |
Long-Term Deferred Tax Liabilities | 1.56 | 1.94 | 2.74 | 3.02 | 3.86 | 0.39 |
Other Long-Term Liabilities | - | 3.93 | 2.87 | 1.96 | 0.95 | - |
Total Liabilities | 915.73 | 901.49 | 838.44 | 760.54 | 618.56 | 459.02 |
Common Stock | 56.03 | 56.03 | 56.03 | 56.03 | 56.03 | 56.03 |
Additional Paid-In Capital | 51.1 | 51.1 | 51.1 | 51.1 | 51.1 | - |
Retained Earnings | 1,625 | 1,522 | 1,373 | 1,505 | 1,347 | - |
Comprehensive Income & Other | - | - | - | - | - | 1,289 |
Shareholders' Equity | 1,733 | 1,630 | 1,480 | 1,612 | 1,454 | 1,345 |
Total Liabilities & Equity | 2,648 | 2,531 | 2,319 | 2,373 | 2,072 | 1,805 |
Total Debt | 76.33 | 72.4 | 80.4 | 0.4 | 0.4 | 0.4 |
Net Cash (Debt) | 671.97 | 511.19 | 577.66 | 1,049 | 299.86 | 283.15 |
Net Cash Growth | 19.58% | -11.51% | -44.95% | 249.97% | 5.90% | -67.13% |
Net Cash Per Share | 1.20 | 0.91 | 1.03 | 1.87 | 0.54 | 0.51 |
Filing Date Shares Outstanding | 560.25 | 560.25 | 560.25 | 560.25 | 560.25 | 560.25 |
Total Common Shares Outstanding | 560.25 | 560.25 | 560.25 | 560.25 | 560.25 | 560.25 |
Working Capital | 453.03 | 238.38 | 475.85 | 1,053 | 318.08 | 392.45 |
Book Value Per Share | 3.09 | 2.91 | 2.64 | 2.88 | 2.59 | 2.40 |
Tangible Book Value | 1,726 | 1,623 | 1,474 | 1,606 | 1,447 | 1,345 |
Tangible Book Value Per Share | 3.08 | 2.90 | 2.63 | 2.87 | 2.58 | 2.40 |
Buildings | - | 238.26 | 238.18 | 259.99 | 189.32 | 157.55 |
Machinery | - | 273.77 | 262.91 | 252 | 193.29 | 172.29 |
Construction In Progress | - | - | 4.9 | - | 147.86 | 124.31 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.